Signal active
Organization
Contact Information
Overview
Docturnal offers custom content for diabetes, heart, cancer, Autism, and Arthritis for users who have a condition or their concerned ones.
The company is a point of care screening and diagnostics provider of non-invasive and proactive detection of diseases. Docturnal’s product portfolio also includes solutions for CoPD and Asthma with a pipeline of lung based ailments that can be identified by an aural component. Docturnal products are designed to make detection of diseases easy and hassle-free. Essentially it means being accessible and affordable to the last mile.
Docturnal was established in April 2016.
About
Biotechnology, Health Care, Diabetes, Health Diagnostics
2016
1-10
Headquarters locations
Andhra Pradesh, India, Asia
Social
N/A
Profile Resume
docturnal headquartered in Andhra Pradesh, India, Asia, operates in the Biotechnology, Health Care, Diabetes, Health Diagnostics sector. The company focuses on Biotechnology and has secured $707.7K in funding across 48 round(s). With a team of 1-10 employees, docturnal is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - docturnal, raised $14.7K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
2
0
$14.7K
Details
3
docturnal has raised a total of $14.7K in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Seed | |||
2017 | Seed | |||
2017 | Seed | 14.7K |
Investors
docturnal is funded by 11 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
AIRmaker | - | FUNDING ROUND - AIRmaker | undefined |
AIM Smart City | - | FUNDING ROUND - AIM Smart City | 14.7K |
docturnal | - | FUNDING ROUND - docturnal | 14.7K |
The IIIT-H Foundation | - | FUNDING ROUND - The IIIT-H Foundation | 14.7K |
Recent Activity
There is no recent news or activity for this profile.